The addition of ProxiSure™ builds upon Ethicon's expansive portfolio of suturing technologies while establishing a new standard of excellence in laparoscopic suturing.Ĭlick to tweet: #ProxiSure enables precise suturing in tight spaces ( ) Ethicon has been a steadfast champion of minimally-invasive surgery, delivering innovative solutions and support services that promote greater procedural expertise, improved hospital outcomes, and better patient care. launch of the ProxiSure™ Suturing Device, an advanced laparoscopic suturing device featuring Ethicon endomechanical, suture and curved needle technologies. Somerville, NJ /PRNewswire/ - Ethicon*, part of the Johnson & Johnson Medical Devices Companies**, announced today the U.S. Ethicon Endo-Surgery does not undertake to update any forward-looking statements as a result of new information or future events or developments.Advanced laparoscopic suturing device features Ethicon's innovative endomechanical, suture and curved needle technologies Copies of this Form 10-K, as well as subsequent filings, are available online at or on request from Johnson & Johnson. A further list and description of these risks, uncertainties and other factors can be found in Exhibit 99 of Johnson & Johnson's Annual Report on Form 10-K for the fiscal year ended December 30, 2007. Risks and uncertainties include general industry conditions and competition economic conditions, such as interest rate and currency exchange rate fluctuations technological advances and patents attained by competitors challenges inherent in new product development, including obtaining regulatory approvals domestic and foreign health care reforms and governmental laws and regulations and trends toward health care cost containment. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from Ethicon Endo-Surgery's expectations and projections. These statements are based on current expectations of future events. (This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. HARMONIC is a trademark of Ethicon Endo-Surgery, Inc. More information can be found at ©2008 Ethicon Endo-Surgery, Inc. "This will serve as a key differentiator in the dynamic advanced energy space."Įthicon Endo-Surgery, Inc., a Johnson & Johnson company, develops and markets advanced medical devices for minimally invasive and open surgical procedures, focusing on procedure-enabling devices for the interventional diagnosis and treatment of conditions in general and bariatric surgery, as well as gastrointestinal health, gynecology and surgical oncology. "The R&D expertise and rich history of innovation of the two companies will enable us to identify emerging patient and surgeon needs and deliver critical solutions to the market more quickly," said Karen Licitra, Company Group Chairman and Worldwide Franchise Chairman, Ethicon Endo-Surgery. The combined portfolio of ENSEAL products and the Ethicon Endo-Surgery HARMONIC line of ultrasonic medical devices will offer greater functionality and flexibility for diverse surgical procedure requirements. This acquisition brings together two leading, complementary energy technologies in the rapidly evolving global energy segment. Terms of the transaction were not disclosed. Ethicon Endo-Surgery announced its agreement to acquire SurgRx, Inc. is a privately held developer of the advanced bipolar tissue sealing system used in the ENSEAL family of devices. Ethicon Endo-Surgery Completes Acquisition of SurgRx, Inc.ĬINCINNATI, OctoEthicon Endo-Surgery announced today that it has completed the acquisition of SurgRx, Inc., following clearance under the Hart-Scott-Rodino Antitrust Improvement Act and similar regulations in other countries.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |